Not yet recruitingNot applicableNCT06344494
Cardiac Interventional ICE Imaging Trial
Studying Hereditary atrial fibrillation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ICE Intelligent Healthcare Co., Ltd
- Principal Investigator
- Deyong Long, MD, PhDBeijing Anzhen Hospital
- Intervention
- Arch EchoTM Intracardiac Ultrasound catheter and ultrasound system(device)
- Enrollment
- 130 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2024 – 2026
Study locations (4)
- Beijing Anzhen Hospital, Capital Medical University, Beijing, Bejing, China
- The First People's Hospital of Changzhou, Changzhou, Jiangsu, China
- The First Hospital Of Jilin University, Changchun, Jilin, China
- Shanghai General Hospital, Shanghai, Shanghai Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06344494 on ClinicalTrials.govOther trials for Hereditary atrial fibrillation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06578104PULSED AF Post-Approval StudyMedtronic Cardiac Ablation Solutions
- RECRUITINGNANCT05951101Zenith LAA Occlusion SystemAuriGen Medical Ltd
- RECRUITINGNCT05190679Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial FibrillationVanderbilt University Medical Center
- RECRUITINGPHASE3NCT04045665Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGIcahn School of Medicine at Mount Sinai